The extent of SNO modification of proteins predicted to contribute to the proliferation of HEMATOPOIETIC cells (ACTB, CDK4, GRB2, GSTP1, VCL, YY1, ANXA1, ANXA2, FLNA, THBS1, HBB, and TCF4) was more pronounced in ChD CS (vs. ChD CA) patients (p: 5.12E-03, z score: 1.0, Figure 8C). This evidence concerns the gene ANXA1 and coronary artery disorder.